August 1, 2017 / 8:52 PM / 2 years ago

BRIEF-Corcept Therapeutics Q2 GAAP earnings per share $0.10

Aug 1 (Reuters) - Corcept Therapeutics Inc

* Corcept Therapeutics announces second quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update

* Q2 non-GAAP earnings per share $0.13

* Q2 GAAP earnings per share $0.10

* Q2 revenue $35.6 million versus I/B/E/S view $32.5 million

* Sees FY 2017 revenue $145 million to $155 million

* Q2 earnings per share view $0.07 — Thomson Reuters I/B/E/S

* FY2017 revenue view $131.9 million — Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below